Davita Inc (DVA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Davita Inc   (NYSE: DVA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Davita Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Davita Inc's ROI in the second quarter of 2026?
Davita Inc achieved a return on average invested assets (ROI) of 7.24 % in its second quarter of 2026, this is above DVA's average return on investment of 6.16%.
Davita Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $16 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 24.79% from the first quarter of 2026.

Within the Healthcare sector 26 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 754 to 1114.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 14.06 % 1.67 % -0.18 % -0.12 % 0.21 %
Y / Y Net Income Change TTM 3.22 % -4.71 % 14.18 % 84.2 % 284.46 %
Investment (TTM) in Millions 22,241 14,632 14,338 14,539 14,559
Return On Investment (TTM) 7.24 % 7.73 % 7.48 % 7.61 % 8 %
DVA's Overall Ranking # 1114 # 754 # 954 # 976 # 883
Seq. Investment Change TTM 13.23 % 0.73 % 0.05 % -0.04 % 0.93 %
Seq. Net Income Change TTM 6.06 % 3.97 % -1.66 % -4.82 % -2.08 %
Net Income (TTM) in Millions 1,190 1,122 1,079 1,097 1,152

DVA Company Profile >> Back to DVA Roi Comparisons >> See Annual DVA Return On Investment



Return On Investment DVA's Ranking
Within: No.
Industry # 7
Sector # 27
Overall # 1114

Return On Investment Statistics
High Average Low
21.54 %
6.16 %
2.06 %
(Dec. 31, 2006)   (Mar 31 2019)







Financial Statements
Davita Inc's II. Quarter Investments $ 22,241 Millions DVA's Balance sheet
Davita Inc's II. Quarter Income $ 343 Millions Quarterly DVA's Income Statement
DVA's Income by Division See DVA's Income by Division


DVA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 14,338 14,312 14,251 14,309 14,723
Y / Y Investment Growth 0.19 % 0.42 % -0.4 % -2.81 % 1.45 %
Net Income in Millions 1,079 1,251 957 782 1,212
Y / Y Net Income Growth -13.75 % 30.7 % 22.43 % -35.5 % 21.82 %
Annual Return On Investment 7.52 % 8.74 % 6.71 % 5.46 % 8.23 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 7.52 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DVA's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DVA's Competitors
Subscribers only: Roi for Davita Inc's Suppliers
Subscribers only: Return On Investment for DVA's Customers

Other Ratios
DVA's Roa DVA's Inventory Turnover Ratio DVA's Growth Rates DVA's Dividend Statistics
DVA's Profitability Ratios DVA's Asset Turnover Ratio DVA's Dividend Growth
DVA's Roe DVA's Valuation Ratios DVA's Financial Strength Ratios DVA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %

Date modified: 2026-09-12T06:12:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.